View Author

Asarfi, A.

( A. Asarfi)


gh treatment treatment group study estrogen turner value height syndrome bmd sds bone mineral density density mineral score group c estrogen therapy bmd sd score 8 iu /m growth fracture trabecular bone 65 girls reference children increment hospital absorptiometry therapy analysis baseline gh dosage groups 4 iu /m pretreatment bone age puberty increase endocrinol hormone bone age reference values turner syndrome growth hormone group b effect phalangeal radiographic absorptiometry dosage peak bone mass adult period 7- y increase radiographic 6 iu /m trabecular study period gh dose netherland method phalanx measurement result sd scores osteoporosis model metab wrist number dutch van leeuwen wj keizer-schrama measurement analysis model incidence reference population turner girls muinck height sd score low-dose estrogens influence low-dose estrogen therapy dutch girls sophia children women




1 Most Recent Publications

Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study (Article)
Sas, T.C.J. Muinck Keizer-Schrama, S.M.P.F. de Stijnen, Th. Teunenbroek, A. van Leeuwen, W.J. van Asarfi, A. Rijn, R.R. van Drop, S.L.S.
2001-01-01